Research articlePublished 2016
Pharmacokinetic Comparison of Two Gabapentin Formulations in Healthy Volunteers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The objective of the study was to establish bioequivalence between a local generic against the innovator product of gabapentin 300 mg. The study design was a standard two-way crossover, open-label, randomised and single dose study in 24 healthy male volunteers under fasting condition. The washout period was 7 days between both periods to allow adequate drug elimination. Liquid chromatography tandem mass spectrometry was utilised to determine gabapentin concentration in plasma. Non-compartmental model was used to analyse Tmax, Cmax, AUC0-t, AUC0-∞, t1/2 and ke. Potential adverse events were closely monitored and recorded throughout the study. The study found all pharmacokinetic parameters were within the bioequivalence limit of 80.00%-125.00%, with minimum side effects. In conclusion, the generic product was bioequivalent to the innovator product.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Wen Yao Mak”
- BylineArticles whose byline prints “Siew Siew Tan”
- BylineArticles whose byline prints “Jia Woei Wong”
- BylineArticles whose byline prints “Siaw Kuen Chin”
- BylineArticles whose byline prints “Ai Boey Lim”
- BylineArticles whose byline prints “Ean Peng Soon”
- BylineArticles whose byline prints “Irene Looi”
- BylineArticles whose byline prints “Kah Hay Yuen”